Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The parathyroid hormone (PTH) stimulates aldosterone secretion and cell proliferation in human adrenocortical cells; moreover, in rats hyperaldosteronism was associated with hyperparathyroidism. Hence, PTH could drive aldosterone excess in human primary aldosteronism. METHOD: To test this hypothesis, we recruited 105 consecutive hypertensive patients, of whom 44 had primary aldosteronism due to an aldosterone-producing adenoma (APA) and 61 had primary (essential) hypertension. We measured the plasma levels of (1-84)-PTH, 25(OH)D, 1,25(OH)2D, and serum Ca (total and ionized), inorganic P, Mg, K, and the 24-h urinary excretion of Ca, P, and deoxypyridinoline. In primary aldosteronism patients, these measurements were repeated after adrenalectomy or mineralocorticoid receptor blockade. We also sought for PTH receptor (PTHR-1) mRNA and protein in APA tissue. RESULTS: Compared with primary (essential) hypertension patients, those with primary aldosteronism showed significantly higher plasma PTH (+31%), despite comparable urinary Ca excretion and similarly deficient 25(OH) vitamin D levels. In APA patients, who showed the PTHR-1 transcript and protein in tumor tissue, adrenalectomy normalized PTH levels (from 118 ± 13 to 76 ± 12 ng/l; P = 0.002) and increased ionized Ca(from 1.17 ± 0.04 to 1.22 ± 0.03 mmol/l; P < 0.001). The slope of the inverse PTH/ionized Ca relationship was steeper in primary aldosteronism than in primary (essential) hypertension, but normalized after adrenalectomy. CONCLUSION: Hence, in primary aldosteronism an increased sensitivity of parathyroid cells to Ca lowering leads to an increase of PTH. This subtle hyperparathyroidism by acting on PTHR-1 in APA might contribute to maintaining hyperaldosteronism despite suppression of angiotensin II formation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationExtracellular Calcium Sensing and Extracellular Calcium Signaling
Brown, E. M., & MacLeod, R. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.239 · Cited by 1,388 · cited 1×
“The alternative hypothesis of PTH resistance was made unlikely by the similar values of U-DPD and cAMP excretion in primary aldosteronismand primary (essential) hypertension patients [16].”
ResultPresidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.
Conn, J. W. (1955) · PubMed · Cited by 955
Calcium metabolism in health and disease
Peacock, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05910809 · Cited by 886 · cited 1×
“Serum ionized Ca2þwas measured in this study with an accurate (intra-assay coefficient of variation less than 2%) electrode-based method and is tightly regulated [20].”
MethodDouma, S., Petidis, K., Doumas, M., Papaefthimiou, P., Triantafyllou, A., Kartali, N., Papadopoulos, N., Vogiatzis, K., & Zamboulis, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60834-x · Cited by 560 · cited 1×
“P rimary aldosteronism is the most common endocrine cause of secondary arterial hypertension in patients referred to specialized hypertension centers [1], or presenting with drug-resistant hypertension [2].”
BackgroundHyperparathyroidism and the Calcium Paradox of Aldosteronism
Chhokar, V. S., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., Myers, L. K., Xing, Z., Smith, R. A., Gerling, I. C., & Weber, K. T. (2005) · Circulation · doi:10.1161/01.cir.0000155621.10213.06 · Cited by 208 · cited 2×
“In rats, administration of aldosterone was associated with an increase of PTH that was attributed to the hypocalcemia induced by the hypercalciuria occurring during the ‘escape phenomenon’ [10,19].”
BackgroundIs There an Unrecognized Epidemic of Primary Aldosteronism? (Pro)
Calhoun, D. A. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.086116 · Cited by 139
Rossi, E., Sani, C., Perazzoli, F., Casoli, M. C., Negro, A., & Dotti, C. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00182-o · Cited by 134 · cited 3×
“The finding that hypocalcaemia was corrected by adrenalectomy in our APA patients (Table 2) is consistent with this interpretation [18].”
ResultPTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells
Mazzocchi, G., Aragona, F., Malendowicz, L. K., & Nussdorfer, G. G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e209 · Cited by 123 · cited 3×
“As PTH acts as an aldosterone secretagogue, an enhancer of other aldosterone secretagogues, and a proliferogenic stimulus for human adrenocortical cells [6,8], these findings might imply that an increase of PTH is instrumental in chronically maintaining aldosterone secretion in primary aldosteronism, despite the suppr…”
BackgroundA comprehensive review of the clinical aspects of primary aldosteronism
Rossi, G. P. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.76 · Cited by 117
Self-citation
Research works printed but not linked: 2
- Hanley, 1993, Parathyroid hormone and parathyroid hormone-related peptide stimulate aldosterone production in the human adrenocortical cell line, NCI-H295., Endocrine J, 1, 447
- Rossi, 2011, Hyperparathyroidism, arterial hypertension and aortic stiffness: a possible bidirectional link between the adrenal cortex and the parathyroid glands that causes vascular damage Hypertens R, es, 34, 286
Cited by
Tomaschitz, A., Ritz, E., Pieske, B., Rus-Machan, J., Kienreich, K., Verheyen, N., Gaksch, M., Grübler, M., Fahrleitner-Pammer, A., Mrak, P., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2013.08.016 · Cited by 166
“to patients with essential hypertension [127].”
BackgroundRossi, G. P., Bisogni, V., Bacca, A., Belfiore, A., Cesari, M., Concistrè, A., Pinto, R. D., Fabris, B., Fallo, F., Fava, C., et al. (2020) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2020.100029 · Cited by 147
Self-citationAldosterone and parathyroid hormone: a precarious couple for cardiovascular disease
Tomaschitz, A., Ritz, E., Pieske, B., Fahrleitner-Pammer, A., Kienreich, K., Horina, J. H., Drechsler, C., Marz, W., Ofner, M., Pieber, T. R., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs092 · Cited by 132
The Biology of Normal Zona Glomerulosa And Aldosterone-Producing Adenoma: Pathological Implications
Seccia, T. M., Caroccia, B., Gómez-Sánchez, E. P., Gómez-Sánchez, C. E., & Rossi, G. P. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00060 · Cited by 120
Self-citationThe renin–angiotensin–aldosterone system and calcium-regulatory hormones
Vaidya, A., Brown, J. M., & Williams, J. S. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.125 · Cited by 93
Metadata
- Authors
- Maniero, C., Fassina, A., Seccia, T. M., Toniato, A., Iacobone, M., Plebani, M., De Caro, R., Calò, L. A., Pessina, A. C., & Rossi, G. P.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Rossi, Gian P.
- ORCID
- Venue
- Journal of Hypertension
- Published
- 2012-02
- Volume
- 30
- Issue
- 2
- Pages
- 390-395
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1997189826
- Cited by
- 87
- References
- 22
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 10 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 2 · 2015: 10 · 2014: 5 · 2013: 8 · 2012: 4
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- mild hyperparathyroidism, primary aldosteronism, aldosterone-producing adenoma, parathyroid hormone, adrenalectomy, mineralocorticoid receptor blockade, vitamin D deficiency, ionized calcium, essential hypertension, hyperaldosteronism, deoxypyridinoline, bone resorption
- MeSH terms
- Adrenalectomy, Adult, Blood Pressure, Calcium, Female, Humans, Hyperaldosteronism, Hyperparathyroidism, Male, Middle Aged, Parathyroid Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. https://app.cochat.ai/papers/10.1097/hjh.0b013e32834f0451
- The paper
- Maniero, C., Fassina, A., Seccia, T. M., Toniato, A., Iacobone, M., Plebani, M., De Caro, R., Calò, L. A., Pessina, A. C., & Rossi, G. P. (2012). Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e32834f0451
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.